The cannabinoid receptor agonist nabilone for the treatment of dementia‐related agitation
暂无分享,去创建一个
[1] Lisa M Eubanks,et al. A molecular link between the active component of marijuana and Alzheimer's disease pathology. , 2006, Molecular pharmaceutics.
[2] D. Kunz,et al. Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia , 2006, Psychopharmacology.
[3] M. L. de Ceballos,et al. Prevention of Alzheimer's Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial Activation , 2005, The Journal of Neuroscience.
[4] J. Romero,et al. Role of the endocannabinoid system in Alzheimer's disease: new perspectives. , 2004, Life sciences.
[5] L. Volicer,et al. Effects of Dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease , 1997, International journal of geriatric psychiatry.